Dolby Laboratories Inc (DLB, Financial) is set to release its Q4 2024 earnings on Nov 19, 2024. The consensus estimate for Q4 2024 revenue is $307.94 million, and the earnings are expected to come in at $0.45 per share. The full year 2024's revenue is expected to be $1.28 billion and the earnings are expected to be $2.54 per share. More detailed estimate data can be found on the Forecast page.
Dolby Laboratories Inc (DLB, Financial) Estimates Trends
Over the past 90 days, the revenue estimates for Dolby Laboratories Inc (DLB) have remained steady at $1.28 billion for the full year 2024 and at $1.33 billion for 2025. Similarly, earnings estimates have remained constant at $2.54 per share for the full year 2024 and at $2.80 per share for 2025.
Dolby Laboratories Inc (DLB, Financial) Reported History
In the previous quarter of June 30, 2024, Dolby Laboratories Inc's (DLB) actual revenue was $288.82 million, which beat analysts' revenue expectations of $286.18 million by 0.92%. Dolby Laboratories Inc's (DLB) actual earnings were $0.40 per share, which beat analysts' earnings expectations of $0.31 per share by 31.15%. After releasing the results, Dolby Laboratories Inc (DLB) was down by -7.18% in one day.
Dolby Laboratories Inc (DLB, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 2 analysts, the average target price for Dolby Laboratories Inc (DLB) is $99 with a high estimate of $100 and a low estimate of $98. The average target implies an upside of 38.75% from the current price of $71.35.
Based on GuruFocus estimates, the estimated GF Value for Dolby Laboratories Inc (DLB, Financial) in one year is $88.62, suggesting an upside of 24.2% from the current price of $71.35.
Based on the consensus recommendation from 4 brokerage firms, Dolby Laboratories Inc's (DLB, Financial) average brokerage recommendation is currently 1.8, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
